Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations

E.R. Pearson; I. Flechtner; P.R. Njolstad; M.T. Malecki; S.E. Flanagan; B. Larkin; F.M. Ashcroft; I. Klimes; E. Codner; V. Iotova; A.S. Slingerland; J. Shield; J. Robert; J.J. Holst; P.M. Clark; S. Ellard; O. Sovik; M. Polak; A.T. Hattersley

Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations

E.R. Pearson, I. Flechtner, P.R. Njolstad, M.T. Malecki, S.E. Flanagan, B. Larkin, F.M. Ashcroft, I. Klimes, E. Codner, V. Iotova, A.S. Slingerland, J. Shield, J. Robert, J.J. Holst, P.M. Clark, S. Ellard, O. Sovik, M. Polak, A.T. Hattersley

720 Citations (Scopus)

Abstract

Udgivelsesdato: 2006/8/3

Original language	English
Journal	New England Journal of Medicine
Volume	355
Issue number	5
Pages (from-to)	467-477
Number of pages	10
ISSN	0028-4793
Publication status	Published - 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Pearson, E. R., Flechtner, I., Njolstad, P. R., Malecki, M. T., Flanagan, S. E., Larkin, B., Ashcroft, F. M., Klimes, I., Codner, E., Iotova, V., Slingerland, A. S., Shield, J., Robert, J., Holst, J. J., Clark, P. M., Ellard, S., Sovik, O., Polak, M., & Hattersley, A. T. (2006). Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. New England Journal of Medicine, 355(5), 467-477.

Pearson, ER, Flechtner, I, Njolstad, PR, Malecki, MT, Flanagan, SE, Larkin, B, Ashcroft, FM, Klimes, I, Codner, E, Iotova, V, Slingerland, AS, Shield, J, Robert, J, Holst, JJ, Clark, PM, Ellard, S, Sovik, O, Polak, M & Hattersley, AT 2006, 'Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations', New England Journal of Medicine, vol. 355, no. 5, pp. 467-477.

@article{1020094070ec11dcbee902004c4f4f50,

title = "Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations",

abstract = "Udgivelsesdato: 2006/8/3",

author = "E.R. Pearson and I. Flechtner and P.R. Njolstad and M.T. Malecki and S.E. Flanagan and B. Larkin and F.M. Ashcroft and I. Klimes and E. Codner and V. Iotova and A.S. Slingerland and J. Shield and J. Robert and J.J. Holst and P.M. Clark and S. Ellard and O. Sovik and M. Polak and A.T. Hattersley",

year = "2006",

language = "English",

volume = "355",

pages = "467--477",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachusetts Medical Society",

number = "5",

}

TY - JOUR

T1 - Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations

AU - Pearson, E.R.

AU - Flechtner, I.

AU - Njolstad, P.R.

AU - Malecki, M.T.

AU - Flanagan, S.E.

AU - Larkin, B.

AU - Ashcroft, F.M.

AU - Klimes, I.

AU - Codner, E.

AU - Iotova, V.

AU - Slingerland, A.S.

AU - Shield, J.

AU - Robert, J.

AU - Holst, J.J.

AU - Clark, P.M.

AU - Ellard, S.

AU - Sovik, O.

AU - Polak, M.

AU - Hattersley, A.T.

PY - 2006

Y1 - 2006

N2 - Udgivelsesdato: 2006/8/3

AB - Udgivelsesdato: 2006/8/3

M3 - Journal article

SN - 0028-4793

VL - 355

SP - 467

EP - 477

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 5

ER -